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Introduction
Breast cancer is the most common lethal neopla-
sm in women. The incidence of breast cancer increases 
dramatically with age: in fact, approximately 70% of 
cases are diagnosed in women aged 50 and older (1).
Breast cancer in older women is the major heal-
th issue and therapeutic challenge. Although there is 
some controversy about the biology of breast cancer 
in the elderly, a general consensus is that age and sta-
ge-related survival is not different in elderly patients 
compared to that in their younger cohorts, except for 
those younger than the age of 40, who are considered to 
have a worse prognosis (1-6). Though the breast cancer 
in elderly patients is commonly diagnosed at a more 
advanced clinical stage (7-12), this may be counterba-
lanced by the fact that patients in the groups of 70 years 
of age and older, are more frequently found to have 
positive  estrogen  and  progesterone  receptors,  which 
generally augur better prognosis (9). Tabor et al. (8,9) 
examined survival rates of women in the 5th, 6th, and 
7th decades with localized and regional breast cancer 
and found them to be the same. Breast cancer in elder-
ly patients, however, is diagnosed at a more advanced 
clinical stage (7,10,11). 
Aims
This study examines specific characteristics of 
breast cancer biology in elderly patients.
Material and methods 
The study population included women treated 
for nonmetastatic breast cancer at the Surgical Clinic 
in Nis between 1999 and 2003. The study group was 
divided into two age groups: patients under 65 years 
of age and patients over 65 years of age. The data were 
obtained from our collected database. Tumor staging 
was conducted according to the TNM system of the 
American  Joint  Committee  on  Cancer  (AJCC). The 
tumor size was measured on histopathological sectio-
ning. The clinical characteristics, tumor histology, and 
axillary status were recorded prospectively for each pa-
tient. Hormone receptor status was measured by using 
biochemist DCC method  or LSAB2 .method.
Results
There were 1098 patients, 667(60,75%) in the 
<65-year old group (younger) and 431(39,25%) in the 
65-year old group (older) treated for breast carcinoma 
(Table 1).
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Table 1. Patients’ characteristics 
≥65 years <65years
Age on diagnosis
Mean age 71,3 50,7
Range 65-83 26-64
Number of patients 431(39,25%) 667(60,75%)
Number of cases 439 686
Synchronous 2 11
Metachronous 6 8
Physical examination
Non-palpable mass 198(45,11%) 301(42,48%)
Palpable mass 241(54,89%) 385(57,72%)
The mean age in the younger group was 50,7 
years (range 26-64) and 71,3 (range 65-83) years in 
the older group. In the younger group, 20 patients had 
bilateral breast cancer during the study period with 11 
synchronous and 8 metachronous events. In the older 
group, there were 8 bilateral breast cancers during the 
study period, 2 synchronous and 6 metachronous oc-
currences. Tumors were discovered only by mammo-
gram more frequently in the younger group (45,11% 
vs. 42,48%) than in the older one. 
Infiltrating ductal carcinoma was the most fre-
quently  observed  histological  type  in  both  groups 
(78,36% vs. 81,05%; p = 0.5236). Patients 65 years old 
or older had larger tumors on diagnosis than younger 
patients. The majority of patients, in the older group 
(35,53%)  compared with the younger ones (35,28%), 
presented with  T2 (2-5cm) tumors. The majority of 
patients, (69,02%) in the older group compared with 
(60,20%) younger one, presented with stage I or II di-
sease. Absence of ipsilateral axillary lymph node invol-
vement was observed in 45,78% and 34,40% of older 
and younger patients, respectively. .Estrogen receptor 
positive tumors occurred in 298 elderly (67,88%)  and 
195 (28,42%) younger patients  (p < 1x10-8). Progeste-
rone receptor positive tumors occurred in 185 (42,15%) 
elderly and 305 (44,46%)  younger patients p = 0.22 
(Table 2).
Discussion
Breast cancer in elderly women is a major health 
issue and therapeutic challenge. This study clearly de-
monstrates that breast cancer in the elderly has distinc-
tive biological and clinical characteristics. Approxima-
tely 40% of the patients’ populations undergoing treat-
ment for breast cancer at our institution are 65 years 
old or older. Almost half of our patients presented with 
mammographically identified lesions.
The detection rate for early-stage non-palpable 
breast cancer in our younger patients was actually sli-
ghtly higher and statistically significant when compa-
red with our  patients older than 65. There has been 
controversy  regarding  the  optimal  screening  recom-
mendations for older patients. There are two potential 
benefits from screening mammography: (1) a reduction 
in breast cancer mortality by making diagnosis earlier, 
and (2) greater likelihood for breast-conserving surge-
ry (12).
The majority of our patients presented with an 
early-stage disease. It is commonly reported that older 
patients present with more advanced disease, but the 
literature is variable on this point (12,13,14,15). The 
finding that older patients had larger tumors than youn-
ger ones could be explained by a delay in the diagno-
sis of breast cancer in older patients because of fewer 
breast (16) and screening mammography (16,17) exa-
minations. A recent study by Busch et al. (18) reported 
that older females were diagnosed at more advanced 
stage. Infiltrating ductal carcinoma, as expected, ac-
counted for the largest percentage of tumors in both 
Table 2. Tumor characteristics by age group
≥65 years <65 years  P-value
Histology
Ductal 344(78,36%) 556(81,05%) 0 .5236
Lobular 55(12,53%) 89(12,97%) 0 .0022
Medullar 19(4,33%) 8(1,17%) 0 .9234
Other 21(4,78%) 33(4,81%)
pT
T1 101(23,01%) 242(35,28%)
T2 156(35,53%) 224(32,65%)
T3 123(28,02%) 198(28,86%)
T4 59(13,44%) 22(3,21%) 0 .000095
Positive lymph nodes
0 201(45,78%) 236(34,40%)
1-3 119(27,11%) 305(44,46%) 0 .0029
>4 101(23,01%) 113(16,47%)
Unknown 18(4,10%) 32(4,67%)
Stage at diagnosis
I 87(19,82%) 125(18,22%) 0 .000083
II 216(49,20%) 288(41,98%) 0 .0013
III 95(21,64%) 214(31,19%) <1x10-8
IV 41(9,34%) 59(8,61%) 0 .000394
Estrogen receptor
Positive 298(67,88%) 195(28,42%) <1x10-8
Negative 81(18,45%) 431(62,83%) <1x10-8
Unknown 60(13,67%) 60(8,75%)
Progesteron receptor
Positive 185(42,15%) 305(44,46%) 0 .22
Negative 210(47,83%) 361(52,62%) 0 .313
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groups. This is reflected in the literature in other series 
(15,19) .
Our  results  confirm  that  elderly  patients  pre-
sent with more favorable prognostic factors (20-22). 
In fact, estrogen receptor positive tumors occurred in 
67,88% of elderly patients versus 28.42% of young  ca-
ses, and negative axillary lymph nodes were observed 
in 45,78% and 34,40% of patients in the elderly and 
younger group, respectively. 
conclusions
There  are  some  clinical  and  pathohistological 
breast cancer specifics in elderly patients. This study 
showed similar pathohistological tumor characteristi-
cs. Our results confirm that older patients present with 
more favorable prognostic factors (estrogen receptor 
positive tumors, negative axillary lymph nodes).
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KLINIČKE I PATOHISTOLOŠKE KARAKTERISTIKE KARcINOMA DOJKE  
KOD BOLESNIcA STARIJE ŽIVOTNE DOBI 
Aleksandar Karanikolić, Vuka Katić, Lidija Đorđević-Jovanović i Dragana Buđevac
Karcinom dojke  žena starije životne dobi danas predstavlja veliki zdravstveni i tera-
pijski problem.  Cilj ove studije bio je da utvrdi specifičnosti biologije karcinoma dojke kod 
bolesnica starije životne dobi.
Retrospektivno su praćene: kliničke i biološke karakteristike tumora dojke kod bole-
snica lečenih tokom petogodišnjeg  perioda  u Hirurškoj klinici-Niš.  Bolesnice su podeljene 
na ispitivanu grupu (≥65 godina) i kontrolnu grupu (<65 godina).
Ispitivanjem je obuhvaćeno 1098 žena: 431 ispitivana i 667 kontrolna grupa. Prosečna 
starosna dob iznosila je 71,3 godina ispitivana i 50,7 godina kontrolna grupa. Najzastupljenija 
histološka forma bila je carcinoma ductale - rani stadijumi (70,3% vs. 61,92%).  Estrogen 
receptor pozitivni tumori bili su kod 67,88% starijih i 28,42% mlađih bolesnica. Odsustvo 
zahvaćenosti aksilarnih limfnih žlezdi bilo je kod 45,78% starijih i 34,40% mlađih bolesnica.
Postoje određene kliničke i patohistološke specifičnosti karcinoma dojke kod bolesni-
ca starije životne dobi. Ova studija je pokazala slične patohistološke karakteristike tumora 
između ispitivane i kontrolne grupe. Utvrđeno je da starije bolesnice poseduju bolje faktore 
prognoze tumora (estrogen receptor pozitivni tumori,  negativne aksilarne limfne žlezde). Acta 
Medica Medianae 2005;44(4): 31 – 34.
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